PDF Cover

Peripheral Vascular Devices Market

The market for Peripheral Vascular Devices was estimated at $11.7 billion in 2025; it is anticipated to increase to $22.3 billion by 2030, with projections indicating growth to around $42.4 billion by 2035.

Report ID:DS1801107
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Peripheral Vascular Devices
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Peripheral Vascular Devices Market Outlook

Revenue, 2025

$11.7B

Forecast, 2035

$42.4B

CAGR, 2026 - 2035

13.7%

The Peripheral Vascular Devices industry revenue is expected to be around $11.7 billion in 2026 and expected to showcase growth with 13.7% CAGR between 2026 and 2035. Contemporary vascular care is increasingly centred on the peripheral vascular devices market, driven by an ageing population, a rise in the prevalence of peripheral artery disease and critical limb ischaemia and by growing cardiovascular risk factors. As a consequence of the trend towards endovascular treatment and minimally invasive surgical procedures, the market for stents is experiencing a significant increase. This growth is primarily driven by efforts to lower recovery periods, increase salvage rates for limbs and enhance the chances of long term success for such procedures. Increasingly complex treatments are being carried out by use of newer angioplasty balloons, peripheral stents, atherectomy devices and thrombectomy devises. There is evidence of continued clinical and economic relevance for peripheral vascular devices, as seen by the increasing adoption of such technology among teams of interventional cardiologists and vascular surgeons worldwide.

Our Peripheral Vascular product range consists of a variety of catheters, guidewires, angioplasty balloons, stent grafts, atherectomy systems, protection devices for use in embolic procedures and devices to close the femoral arteriotomy after angiography. Critical limb ischaemia and peripheral artery disease represent two application region's that currently dominate the market. They make up 64.7 % of the current application field, reflecting the high volume of treatments needed for these conditions. In the year 2025 the sale of disposable of peripheral vascular devices is forecast to be $10.24 billion, primarily comprising products such as catheters, sheaths and related disposable consumables. This reflects the current preference in these environments for sterilisation, consistency and a more efficient workflow. The key drivers of increasing demand are developments such as bioresorbable scaffolds and drug coated technologies, a rise in the employment of technology which guides images and less invasive treatments for the blood vessels which are performed outside hospital.

Peripheral Vascular Devices market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Peripheral Vascular Devices Market Outlook

Market Key Insights

  • The Peripheral Vascular Devices market is projected to grow from $11.7 billion in 2025 to $42.4 billion in 2035. This represents a CAGR of 13.7%, reflecting rising demand across Vascular Angioplasty, Aortic Aneurysm Repair, and Chronic Total Occlusion (CTO) Procedures.

  • The competitive landscape of this market is determined by major players such as Boston Scientific, Abbott and Medtronic.

  • The U.S. and Germany are likely to lead the peripheral vascular devices market. These two countries are expected to increase at a compound annual growth rate of 12.3% to 16.4% from the years 2025 to 2030.

  • The highest growth rates, with a compound annual growth rate of anything between 9.6 and 14.4% , are predicted for the emerging markets of India, Brazil and South Africa.

  • The trend towards less invasive surgical methods will cause the market for Peripheral Vascular Devices to be $3 billion larger by 2030.

  • Over the period of 2025 to 2035, peripheral vascular devices market is predicted to be worth thirty billion, six hundred million dollars. The target market is peripheral vascular diseases which are clinically manifested as critical limb ischemia and aneurysms.

  • Given that there is a growing incidence of peripheral vascular disorders and device innovations resulting from the latest technology, the global peripheral vascular devices market will rise by 261% from 2025 to 2035.

peripheral vascular devices market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Peripheral Vascular Devices - Country Share Analysis

Opportunities in the Peripheral Vascular Devices

With the trend in outpatient and ambulatory centres for short stay, cost effective treatments, worldwide there is also a growing interest in vascular devices that facilitate same day discharge. The natural environment of the body makes it easier for next generation drug coated balloons for angioplasty, biocompatible absorbable stents and IVC devices of reduced profile which decrease restenosis and reduces the complications which may occur. In countries where healthcare is paid for and where healthcare systems are shifting more towards outpatient surgery, there is likely to be faster growth in the demand for these medical devices.

Growth Opportunities in North America and Europe

Demand for peripheral vascular devices in North America is driven by a heightened awareness of peripheral vascular disease and its symptoms. The market for treatments of peripheral artery disease is most notable, closely followed by the growing demand for critical limb ischaemia treatments in below the knee conditions; this positions PAD focused endovascular devices and atherectomy devices as key opportunities. Global companies in the field are facing stiff competition from innovative regional companies that can offer differentiation via drug eluting technology, imaging and the integration of imaging and medical devices and also efficient systems for medical procedures. This regions healthcare sector is dominated by a population which is aging and this group is highly at risk from heart conditions. The region offers good reimbursement for endovascular treatments. There is also strong evidence based clinical pathways. There is growth in the number of out patient vascular treatment clinics, giving scope for the introduction of more expensive vascular equipment and new technologies for treating vein conditions as well as a need for new devices to prevent the amputation of limbs in those with a high risk of this occurring.
Peripheral Vascular Devices have a considerable impact in Europe, where screening and treatment guidelines significantly influence the use of this class of products. The main applications of Peripheral Vascular Devices are in aneurysm repair and PAD interventions, where the demand for stent grafts and balloon catheters is driven by the combined demand for treatment of abdominal aortic aneurysms and lower extremity PAD. The treatment of peripheral artery disease and aneurysms in Europe is mainly performed using endovascular techniques which involves the use of stent grafts and balloon catheters. These are used to treat lower extremity PAD and abdominal aortic aneurysms. The main demand for Peripheral Vascular Devices is driven by the need to treat lower extremity PAD and abdominal aortic aneurysms in Europe. Companies are focusing on devices that allow for vascular treatment at a lower cost. This includes treatments for chronic conditions where patients can save money by not only needing extended hospital stays. The interventional cardiology marketplace is marked by the significant influence of both a handful of global leaders and a number of European innovators that have developed a niche for themselves through competitive innovation in the region's of device deliverability, radiation dose reduction and procedure standardisation. Factors likely to spur growth in the market include an ageing population, increased numbers of screenings for aneurysms and the peripheral arterial disease, the development of hybrid operating rooms and an increased adoption rate for drug eluting stents and bioresorbable stent technology.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Peripheral Artery Disease and Increasing Demand for Minimally Invasive Procedures

The growth of the peripheral vascular devices market is also strongly driven by the rising prevalence of peripheral artery disease (PAD) and the increasing adoption of minimally invasive interventions. PAD, caused by atherosclerosis, affects millions globally, particularly older adults and patients with diabetes or hypertension, creating sustained demand for revascularization solutions. Minimally invasive procedures such as balloon angioplasty, stent placement, and endovascular aortic repair reduce patient recovery time, hospital stay, and procedural complications compared to open surgery. Peripheral vascular devices like drug-eluting stents, microcatheters, and specialized guidewires enable clinicians to treat complex lesions with precision. Innovations such as coated stents, low-profile delivery systems, and hydrophilic guidewires further enhance procedural efficiency and success rates. Together, the increasing PAD burden and the shift toward minimally invasive techniques drive higher adoption of peripheral vascular devices in hospitals, specialized vascular centers, and interventional cardiology clinics worldwide.
A key driver is also the development of advanced stent coatings, low-profile delivery systems, and specialized guidewires. These innovations improve device navigation, reduce vessel trauma, and lower restenosis risk during peripheral interventions. Enhanced designs enable clinicians to manage complex lesions, chronic total occlusions, and tortuous anatomies with higher precision. This technological progression increases procedural success rates, improves patient outcomes, and encourages adoption in tertiary care hospitals and specialized vascular intervention centers.
02

Restraint: High Procedure Costs and Limited Reimbursement Reduce Adoption in Emerging Regions

The high costs of peripheral vascular devices and inconsistent reimbursement policies constrain market growth, especially in emerging economies. Advanced stent graft systems, drug‑eluting stents, and specialized CTO equipment carry premium pricing, which can be prohibitive for budget‑limited hospitals and outpatient centers. Without adequate reimbursement for peripheral interventions, many providers delay or avoid adopting such technologies, suppressing demand and slowing revenue growth for manufacturers targeting broad global penetration.
03

Opportunity: High-growth demand for Peripheral Vascular Devices in emerging Asia-Pacific endovascular therapy centers and clinics and Peripheral Vascular Devices adoption for peripheral artery disease in leading United States hospitals and clinics

In countries such as China, India and the countries of South east Asia the big untreated patient base and the upgrading of hospital infrastructure in these region's presents considerable opportunities for Peripheral Vascular Devices. Due to screening, it is being identified that there are more people who have critical limb ischaemia. As a result of this, manufacturers of peripheral guidewires, catheters and stents are seeing an increase in demand for their advanced products. The global market for this product will be comprised of a particular region that will be valued at around $1.49 bln in the year 2025. It is estimated that by the year 2030, the market will expand to be worth approximately $2.31 bln. This growth will be seen at a rate of 9.19% every year in these regions.
US hospitals are being placed under increased strain due to the growing numbers of people suffering with diabetes, combined with a growing older population, and as a result, the problem of peripheral artery disease is worsening. The increasing demand for minimally invasive treatments is accelerating the adoption of peripherial vascular devices. This is occurring in vascular surgery and cardiology departments, where preference is being given to endovascular procedures over open bypass surgeries. By 2030, a predicted increase of nearly $20 billion over 2025s $10 billion is forecasted, in the global revenue. This represents a compound annual growth rate of 14.3%. The year 2025s revenue is projected to be $10.24 billion. In this sector, it is the coronary stents, catheters, guidewires and angioplasty balloons which are growing fastest.
04

Challenge: Risk of Complications and Preference for Alternative Therapies Hinders Device Utilization

Concerns over procedure‑related complications such as restenosis, embolization, or vessel perforation act as significant restraints. Some clinicians may favor pharmacological management or conservative care over invasive peripheral interventions, especially for moderate cases. This risk aversion alters treatment decisions, reducing procedural volumes and dampening demand for high‑end devices. Consequently, lower utilization affects market dynamics, leading to selective purchasing and slower uptake of next‑generation vascular technologies.

Supply Chain Landscape

1

Vascular Materials Sourcing

W. L. Gore & AssociatesDSM BiomedicalEvonik Industries
2

Peripheral Vascular Devices

Boston ScientificMedtronicAbbott
3

Endovascular Distribution Network

Cardinal HealthOwens & MinorMedline Industries
4

Clinical End Users

HospitalsAmbulatory Surgical CentersCardiology Clinics
Peripheral Vascular Devices - Supply Chain

Use Cases of Peripheral Vascular Devices in Angioplasty & Aortic Aneurysm Repair

Vascular Angioplasty : In vascular angioplasty, peripheral vascular devices such as balloon catheters and peripheral stents are predominantly used to treat arterial narrowing in peripheral arteries. These devices enable minimally invasive revascularization, restoring blood flow while reducing recovery time and procedural risk compared to open surgery. Leading players like Medtronic, Boston Scientific, Abbott, and Terumo provide advanced balloon and stent technologies with drug-eluting or coated options. Their products offer precise deployment, enhanced vessel patency, and reduced restenosis rates, making them preferred choices in interventional cardiology and vascular surgery centers.
Aortic Aneurysm Repair : For aortic aneurysm repair, endovascular stent graft systems are the primary peripheral vascular devices utilized. These devices allow minimally invasive treatment of thoracic or abdominal aortic aneurysms by providing structural support and preventing rupture. Manufacturers such as Gore Medical, Medtronic, and Cook Medical dominate this space by offering modular, flexible, and highly durable stent graft systems. Their solutions improve procedural safety, reduce hospital stay, and enable treatment of complex aneurysm anatomies, reinforcing their leadership in the vascular device market.
Chronic Total Occlusion (CTO) Procedures : In CTO procedures, specialized guidewires, microcatheters, and crossing devices are commonly employed to recanalize completely occluded peripheral arteries. These peripheral vascular devices facilitate access to challenging lesions with precision and minimize vessel trauma. Companies such as Boston Scientific, Abbott, and Terumo offer dedicated CTO device portfolios designed for improved pushability, torque response, and support during complex interventions. These technologies enhance procedural success rates, reduce fluoroscopy time, and are highly valued in tertiary care hospitals and specialized interventional cardiology centers.

Recent Developments

Recent developments in the peripheral vascular devices market reflect strong momentum in endovascular therapy and interventional cardiology innovations. Manufacturers are advancing peripheral stents, balloon angioplasty systems, and stent graft technologies that enhance vascular access, deliverability, and long‑term patency. A key trend is the rise of drug‑coated and bioresorbable devices, which aim to reduce restenosis and improve clinical outcomes in peripheral artery disease and aortic aneurysm repair. These innovations are driving adoption across hospitals, vascular centers, and specialty clinics.

April 2024 : Abbott Laboratories received FDA approval for the Esprit BTK Everolimus Eluting Bioresorbable Scaffold System for below‑the‑knee peripheral artery disease, marking a regulatory milestone for bioresorbable peripheral stents. 
March 2024 : Becton Dickinson and Company (BD) commercially launched a new peripheral vascular stent system in Europe designed to improve vessel patency in PAD patients.

Impact of Industry Transitions on the Peripheral Vascular Devices Market

As a core segment of the Medical Device industry, the Peripheral Vascular Devices market develops in line with broader industry shifts. Over recent years, transitions such as Shift towards Minimally Invasive Surgeries and Embracing Digital and AI Technologies have redefined priorities across the Medical Device sector, influencing how the Peripheral Vascular Devices market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Shift towards Minimally Invasive Surgeries

Minimally invasive treatments are becoming increasingly more popular and are changing the world of peripheral vascular devices. Endovascular treatments for the conditions peripheral artery disease and chronic limb ischaemia are now generally preferred to surgery as they require less recovery time, cause fewer complications and reduce hospital stays. Technologies including drug coated balloons, plaque modification devices, stent grafts and drug eluting stents have been at the heart of advancements within the field. This has led to quicker, more effective treatments with better long term results. This clinical and technological shift will not only be an incremental move. It could increase the Peripheral Vascular Devices market by $3 billion by 2030. As a result, the outlook for the makers of minimally invasive vascular treatments is improved and the adoption of such treatments by hospitals, clinics and ambulatory surgical centres will accelerate.
02

Embracing Digital and AI Technologies

Changes in the market are resulting from an increasing reliance on digital technology and AI. Enhanced procedural accuracy, device performance and patient care are being achieved by manufacturers using AI in the design and production of medical devices which are used to treat the vascular system. The predictive analytics employed by businesses using AI also assist in determining when there is likely to be demand and in supplying goods to retailers before sales begin. These technologies along with the connectivity of smart devices and digital monitoring systems are driving innovation in the vascular devices industry, leading to increased efficiency and precision.